| Literature DB >> 30994937 |
Pengqing Nie1,2,3, Zhiqiang Li3, Yimeng Wang1,3, Yubing Zhang1,3, Mengna Zhao1,3, Jie Luo2, Shiming Du2, Zixin Deng1, Jincao Chen3, Yunfu Wang2, Shi Chen1,2,3, Lianrong Wang1,2,3.
Abstract
Ongoing studies have determined that the gut microbiota is a major factor influencing both health and disease. Host genetic factors and environmental factors contribute to differences in gut microbiota composition and function. Intestinal dysbiosis is a cause or a contributory cause for diseases in multiple body systems, ranging from the digestive system to the immune, cardiovascular, respiratory, and even nervous system. Investigation of pathogenesis has identified specific species or strains, bacterial genes, and metabolites that play roles in certain diseases and represent potential drug targets. As research progresses, gut microbiome-based diagnosis and therapy are proposed and applied, which might lead to considerable progress in precision medicine. We further discuss the limitations of current studies and potential solutions.Entities:
Keywords: brain disorders; cancer; gut microbiota; gut microbiota modulation; immune response; metabolic disorders; systemic inflammation
Mesh:
Year: 2019 PMID: 30994937 DOI: 10.1002/med.21584
Source DB: PubMed Journal: Med Res Rev ISSN: 0198-6325 Impact factor: 12.944